South Wales, Sept. 24 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "LYVANTA" on July 2. The details about the trademark application no. UK00004228173 published in the journal no. 2025/038 (Sept. 19).
With Potter Clarkson LLP as representative, U-Ploid Biotechnologies Ltd filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Fertility-enhancing drugs; pharmaceuticals and medical preparations; pharmaceutical and medical preparations for fertility treatments; ovulation stimulants; drugs that stimulate ovulation to aid in conception; supplements for reproductive health; diagnostic reagents for medical use; implantation support supplements; hormonal therapies being pharmaceutical preparations; In vitro fertilization (IVF) media; cryopreservation solutions; semen analysis kits; endometrial receptivity tests; luteal phase support; tests to measure ovarian reserve and predict response to fertility treatments; tests to evaluate ovarian function and fertility potential; nutrient solutions used to support the growth of embryos in the lab; implantation support supplements.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004228173
Disclaimer: Curated by HT Syndication.
